Exon skipping quantification by real-time PCR.

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Duchenne muscular dystrophy (DMD) is a severe genetic disorder.
• Antisense oligonucleotide (AON)-mediated exon skipping offers a therapeutic strategy for DMD by restoring dystrophin protein production.
• Current evaluation methods for AON efficacy need improvement in sensitivity and specificity.

Purpose of the Study:

• To develop and describe a novel, sensitive, and specific real-time PCR-based assay for evaluating AON-mediated exon skipping.
• To provide a reproducible method for assessing therapeutic effectiveness in preclinical and clinical settings.

Main Methods:

• Development of a probe-based real-time PCR protocol.
• Design of an exon-specific real-time assay targeting sequences within the exon of interest.
• Application of the assay in cells, animal models, and human samples.

Main Results:

• The developed exon-specific real-time assay demonstrates high sensitivity and specificity.
• The protocol is highly reproducible, enabling reliable evaluation of AON treatment effectiveness.
• This method facilitates accurate monitoring of therapeutic outcomes in DMD.

Conclusions:

• The described real-time PCR assay is a valuable tool for quantifying exon skipping efficiency.
• This assay supports the advancement of AON-based therapies for Duchenne muscular dystrophy.
• The method is crucial for the ongoing clinical trials and future development of DMD treatments.